Skip to main content
Iris Broce-Diaz

Iris Broce-Diaz

Assistant Professor of Neurosciences at UC San Diego School of Medicine, developing multimodal tools for early Alzheimer's detection

Aug 6, 2026

0:23
well thank you so much for inviting me yeah i'm iris and i'm in the department of neurosciences so um thank you for giving me the opportunity to talk like what for six seconds for the work that i'm doing and um So I have this grant that I just recently got awarded from the Wellcome Care Lead Program.
0:47
And really, their whole focus is on Alzheimer's disease prevention in women.
0:52
And so Alzheimer's disease is a progressive neurodegenerative condition that impairs your memory and cognition and affects millions of people worldwide.
1:04
What I'm trying to do is develop these accessible, non-invasive, cost-effective tools that can help primary care and neurologists in an early detection of Alzheimer's disease.
1:16
Really, to create a tool and deploy it in the clinics and make it accessible here and worldwide, we're starting with standard of care tools.
1:27
um and so what's considered standard of care is very different in a high resource center versus a low resource center versus here versus latin america versus europe and that's really interesting but we are starting here at ucsd and diagnosing dementia really does start in primary care and so usually like a patient will report a concern or the family member And then the primary care, they don't have a lot of time, but they'll order some standard labs.

8 MINS LATER

speaker_4AUDIENCE
10:11
How do we get it that standard so that this actually makes a difference?
10:15
is so interesting because you're right.
speaker_0NARRATOR
0:11
Visit uctv.tv/motherhood for more.
0:15
Well, thank you so much for inviting me.
0:17
Yeah, I'm Iris, and I'm in the Department of Neurosciences.
0:22
So, um, thank you for giving me the opportunity to talk, like what, for six seconds for the work that I'm doing.
0:29
[laughs] And, um, so, um, I have this grant that I just recently got awarded from the Welcome Care Leap program.
0:38
Um, and really, their whole focus is on Alzheimer's disease prevention in women.
0:44
And so Alzheimer's disease is a progressive neurodegenerative condition that really impairs your memory and cognition and, like, affects millions of people worldwide.

9 MINS LATER

speaker_5UNKNOWN
10:02
But how do we get it that standard so that this actually makes a difference?
speaker_0ANNOUNCER
0:11
Visit uctv.tv/motherhood for more.
0:15
Well, thank you so much for inviting me.
0:17
Yeah, I'm Iris, and I'm in the Department of Neurosciences.
0:22
So, um, thank you for giving me the opportunity to talk, like what? For six seconds for the work that I'm doing.
0:29
[laughs] And, um, so, um, I have this grant that I just recently got awarded from the Welcome Care Leap program.
0:38
Um, and really their whole focus is on Alzheimer's disease prevention in women.
0:44
And so Alzheimer's disease is a progressive neurodegenerative condition that really impairs your memory and cognition and, like, affects millions of people worldwide.

9 MINS LATER

speaker_5UNKNOWN
9:55
Like, how do we get it so every five years, um, some kind of risk tiering maybe based on family history or something like that? But how do we get it that standard so that this actually makes a difference?
0:23
well thank you so much for inviting me yeah i'm iris and i'm in the department of neurosciences so um thank you for giving me the opportunity to talk like what for six seconds for the work that i'm doing and um So I have this grant that I just recently got awarded from the Wellcome Care Lead Program.
0:47
And really, their whole focus is on Alzheimer's disease prevention in women.
0:52
And so Alzheimer's disease is a progressive neurodegenerative condition that impairs your memory and cognition and affects millions of people worldwide.
1:04
What I'm trying to do is develop these accessible, non-invasive, cost-effective tools that can help primary care and neurologists in an early detection of Alzheimer's disease.
1:16
Really, to create a tool and deploy it in the clinics and make it accessible here and worldwide, we're starting with standard of care tools.
1:27
um and so what's considered standard of care is very different in a high resource center versus a low resource center versus here versus latin america versus europe and that's really interesting but we are starting here at ucsd and diagnosing dementia really does start in primary care and so usually like a patient will report a concern or the family member And then the primary care, they don't have a lot of time, but they'll order some standard labs.

8 MINS LATER

speaker_4PANELIST
10:11
How do we get it that standard so that this actually makes a difference?
10:15
is so interesting because you're right.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.